Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by 
human Tau ΔK280

Dennissen, Frank J. A.; Anglada-Huguet, Marta; Sydow, Astrid; Mandelkow, Eckhard; Mandelkow, Eva-Maria

doi:doi: 10.1073/pnas.1603119113

Item

ITEM ACTIONSEXPORT

Add to Basket

Please note that a newer version of this item is available:
https://pure.mpg.de/pubman/item/item_2351476_3

DetailsSummary

Released

Journal Article

Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau ΔK280

MPS-Authors

/persons/resource/persons94203

Mandelkow, Eckhard
Neuronal Cytoskeleton and Alzheimer's Disease, Cooperations, Center of Advanced European Studies and Research (caesar), Max Planck Society;

/persons/resource/persons128150

Mandelkow, Eva-Maria
Neuronal Cytoskeleton and Alzheimer's Disease, Cooperations, Center of Advanced European Studies and Research (caesar), Max Planck Society;

External Resource

http://www.pnas.org/content/early/2016/09/21/1603119113.abstract
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Dennissen, F. J. A., Anglada-Huguet, M., Sydow, A., Mandelkow, E., & Mandelkow, E.-M. (2016). Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau ΔK280. Proceedings of the National Academy of Sciences of the United States of America, 170(6), 1167-1176. doi:doi: 10.1073/pnas.1603119113.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002B-8D9D-2

Abstract

There is no abstract available